Skip to main content
BCLI logo

BCLI

Brainstorm Cell Therapeutics Inc.
$1.44 +0.15 (+11.63%) At close · Jul 2
Market Cap
$15.89M
Shares
11,034,775

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 5
Total Value: $1,643
Total Shares: 2,317

Institutional Ownership Trend

5 quarters

Holder Concentration

Across 5 13F filers · Δ vs Jun 30, 2025
Top Holder
77.1%
Sep 2024 → Sep 2025 · range 40.0% – 92.5%
+37.1 pts
Top 5
100.0%
Sep 2024 → Sep 2025 · range 73.9% – 100.0%
+26.1 pts
Top 10
100.0%
Sep 2024 → Sep 2025 · range 92.4% – 100.0%
+7.6 pts
HHI
6,130
Sep 2024 → Sep 2025 · range 2,012 – 8,611
Highly concentrated+4,119

Quarterly Activity

vs Jun 30, 2025
New
0
Increased
0
Decreased
0
Sold Out
30
Unchanged
5
Holder count: -30
Institutional value: -99.6%
Shares held: -99.4%

Top New Positions

vs Jun 30, 2025
No new positions this quarter.

Top Sold-Out Positions

vs Jun 30, 2025
Institution Previously Held Last Value (USD) Open
Showing 5 of 5
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1137883 CUSIP 10501E300 Visit website Investor relations